Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000919574-26-007577·Edesa Biotech, Inc.
Schedule 13G ownership disclosure
EDESA BIOTECH INC
Common Shares, no par value per share · CUSIP: 27966L306
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Adage Capital Management, L.P.
Shares: 1,100,000.00 · Class: 7.83%
- Robert Atchinson
Shares: 1,100,000.00 · Class: 7.83%
- Phillip Gross
Shares: 1,100,000.00 · Class: 7.83%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-26-007577
- Form type
- SCHEDULE 13G
- Filer
- Edesa Biotech, Inc.
- CIK
- CIK 1540159
- Filed
- Nov 12, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership